Second Sight Medical (EYES) Prices 7.5M Share Common Offering at $1/Sh

Second Sight Medical Products Inc. (NASDAQ: EYES) today announced the pricing of an underwritten public offering of 7,500,000 shares of common stock, no par value (the “Common Stock”) at an offering price of $1.00 per share of Common Stock for aggregate gross proceeds of $7,500,000, prior to deducting underwriting discounts, commissions and other offering expenses. The offering is expected to close on May 5, 2020, subject to the satisfaction of customary closing conditions.

Second Sight Medical Products intends to use the net proceeds from the offering for accrued expenses, working capital and general corporate purposes, which may include, without limitation, engaging in partnerships, business combinations, or acquisitions or investing in businesses that may or may not be related to its current operations.

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as representative of the underwriters in the offering.

You May Also Be Interested In

• QNB Corp. overallotment option adds 160,714 shares at $42 each
• LiveRamp shrinks board to six directors after resignation
• Edesa Biotech prices $25M public offering on Nasdaq